세계의 의약품 CDMO 시장 보고서(2025년)

A pharmaceutical contract development and manufacturing organization (CDMO) for formulations is a company that offers outsourced services to support the development and production of drug formulations on behalf of pharmaceutical companies. These services typically include formulation development, analytical testing, production of clinical trial materials, and large-scale commercial manufacturing.

The primary types of dosage forms provided by pharmaceutical CDMOs for formulations include oral solids, oral liquids, injectables, topicals, inhalation products, transdermals and patches, among others. Oral solid dosage forms are medications administered orally and designed to deliver the active drug through the digestive system. These dosage forms are applied across various therapeutic areas such as oncology, cardiology, central nervous system disorders, gastroenterology, infectious diseases, and endocrinology. The services are utilized by a range of end users, including pharmaceutical companies, biopharmaceutical firms, and other related organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The pharmaceutical contract development and manufacturing organizations (CDMO) for formulations market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical contract development and manufacturing organizations (CDMO) for formulations market statistics, including the pharmaceutical contract development and manufacturing organizations (CDMO) for formulations industry global market size, regional shares, competitors with the pharmaceutical contract development and manufacturing organizations (CDMO) for formulations market share, detailed pharmaceutical contract development and manufacturing organizations (CDMO) for formulations market segments, market trends, opportunities, and any further data you may need to thrive in the pharmaceutical contract development and manufacturing organizations (CDMO) for formulations industry. This pharmaceutical contract development and manufacturing organizations (CDMO) for formulations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market size has grown rapidly in recent years. It will grow from $49.32 billion in 2024 to $54.73 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth during the historic period can be attributed to the rise in pharmaceutical outsourcing, increasing complexity of drug formulations, cost-reduction strategies adopted by pharmaceutical companies, growing demand for generics and biosimilars, and the expansion of small and mid-sized pharmaceutical firms.

The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market size is expected to see rapid growth in the next few years. It will grow to $82.15 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the surge in biologics and advanced therapies, the expansion of personalized medicine, increasing emphasis on continuous manufacturing, regulatory encouragement for outsourcing, and the rising adoption of digitalization and automation in pharmaceutical production. Key trends anticipated during this period include the advancement of continuous manufacturing technologies, integration of AI and machine learning in drug development processes, expansion of high-potency API (HPAPI) handling capabilities, increased adoption of biologics and complex injectable formulations, and a growing focus on sustainable and environmentally friendly manufacturing practices.

The increasing activities in drug development and manufacturing are expected to drive the growth of the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market. Drug development and manufacturing refer to the efforts by pharmaceutical and biopharmaceutical companies to research, develop, and produce new therapeutic drugs. These activities are rising due to the growing global demand for novel and effective treatments, which encourages companies to broaden their development pipelines and accelerate production timelines. CDMOs support this process by formulating and optimizing dosage forms, conducting stability testing, ensuring regulatory compliance, and managing scale-up and production. This enables quicker and more cost-effective product launches. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based pharmaceutical industry trade group, reported that pharmaceutical production in Europe reached $422.8 billion (€390 billion) in 2023, up from $393.9 billion (€363.3 billion) in 2022. Therefore, the expansion of drug development and manufacturing is contributing to the growth of the CDMO market for formulations.

Leading companies in the pharmaceutical CDMO for formulations market are focusing on the development of advanced biologic formulation platforms to improve drug stability and speed up delivery timelines for complex biologic therapies. These biologic formulation platforms are specialized systems that optimize various formulation parameters-such as pH levels, excipients, and delivery mechanisms-to enhance the stability, safety, and bioavailability of biologic drugs throughout their lifecycle. For example, in June 2025, WuXi Biologics, a China-based contract research, development, and manufacturing company, introduced WuXiHigh 2.0, a next-generation high-concentration formulation platform. This platform allows biologic formulations with protein concentrations up to 230 mg/mL, exceeding the FDA-approved limit of 200 mg/mL. It also reduces viscosity by up to 90% through proprietary excipient blends and high-throughput screening. WuXiHigh 2.0 addresses key challenges in high-concentration biologics-such as aggregation and viscosity-while improving injection efficiency, patient compliance, and manufacturing performance throughout the clinical and commercial stages.

In February 2025, Jabil Inc., a US-based provider of engineering, manufacturing, and supply chain services, acquired Pharmaceutics International Inc. (Pii) for an undisclosed amount. This acquisition is intended to enhance Jabil's capabilities in pharmaceutical manufacturing and development by leveraging Pii's expertise in aseptic filling, lyophilization, and oral solid dose production. It strengthens Jabil's position in parenteral drug delivery and broadens its comprehensive support across both clinical and commercial manufacturing. Pharmaceutics International Inc. (Pii) is a US-based CDMO that offers formulation development services for a variety of drug forms, ranging from injectable to oral products.

Major players in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market are Thermo Fisher Scientific Inc., Lonza Group, Catalent Inc., WuXi Biologics, Samsung Biologics, Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, Altasciences, Hovione, Aurigene Pharmaceutical Services Ltd., DPT Laboratories Ltd., CARBOGEN AMCIS, Biopharma Group, LGM Pharma, and Aarti Pharmalabs Limited.

Asia-Pacific was the largest region in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical contract development and manufacturing organization (CDMO) for formulations report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market consists of revenues earned by entities by providing services such as analytical and stability testing, formulation development, process development and scale-up, regulatory support and documentation, and commercial-scale manufacturing and packaging. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market also includes sales of suppositories, ophthalmic preparations, buccal and sublingual tablets, liposomal formulations, and microneedle patches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical contract development and manufacturing organization (cdmo) for formulations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical contract development and manufacturing organization (cdmo) for formulations ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical contract development and manufacturing organization (cdmo) for formulations market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Dosage Form: Oral Solids; Oral Liquids; Injectables; Topicals; Inhalation Products; Transdermal And Patches; Other Dosage Forms
• 2) By Therapeutic Area: Oncology; Cardiology; Central Nervous System; Gastroenterology; Infectious Diseases; Endocrinology
• 3) By End-User: Pharmaceutical Companies; Biopharmaceutical Companies; Other End-Users
• Subsegments:
• 1) By Oral Solids: Tablets; Capsules; Granules; Powders; Modified-Release Formulations
• 2) By Oral Liquids: Syrups; Suspensions; Solutions; Emulsions; Elixirs
• 3) By Injectables: Vials; Ampoules; Prefilled Syringes; Lyophilized Injections; Injectable Emulsions
• 4) By Topicals: Creams; Ointments; Gels; Lotions; Foams;
• 5) By Inhalation Products: Metered Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizer Solutions; Nasal Sprays; Inhalation Capsules
• 6) By Transdermal And Patches: Matrix Patches; Reservoir Patches; Drug-In-Adhesive Patches; Microneedle Patches; Iontophoretic Patches
• 7) By Other Dosage Forms: Suppositories; Ophthalmic Preparations; Buccal Tablets; Sublingual Tablets; Implants
• Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group; Catalent Inc.; WuXi Biologics; Samsung Biologics; Recipharm AB; Siegfried Holding AG; Evonik Industries AG; Almac Group; Aenova Group; Piramal Pharma Limited; Cambrex; Jubilant Pharmova Limited; CordenPharma; Altasciences; Hovione; Aurigene Pharmaceutical Services Ltd.; DPT Laboratories Ltd.; CARBOGEN AMCIS; Biopharma Group; LGM Pharma; Aarti Pharmalabs Limited.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Characteristics

3. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Trends And Strategies

4. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Total Addressable Market (TAM)

6. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Segmentation

• 6.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Solids
• Oral Liquids
• Injectables
• Topicals
• Inhalation Products
• Transdermal And Patches
• Other Dosage Forms
• 6.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiology
• Central Nervous System
• Gastroenterology
• Infectious Diseases
• Endocrinology
• 6.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Other End-Users
• 6.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Solids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Granules
• Powders
• Modified-Release Formulations
• 6.5. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Liquids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Syrups
• Suspensions
• Solutions
• Emulsions
• Elixirs
• 6.6. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vials
• Ampoules
• Prefilled Syringes
• Lyophilized Injections
• Injectable Emulsions
• 6.7. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Topicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Creams
• Ointments
• Gels
• Lotions
• Foams
• 6.8. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Inhalation Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs)
• Nebulizer Solutions
• Nasal Sprays
• Inhalation Capsules
• 6.9. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Transdermal And Patches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Matrix Patches
• Reservoir Patches
• Drug-In-Adhesive Patches
• Microneedle Patches
• Iontophoretic Patches
• 6.10. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Suppositories
• Ophthalmic Preparations
• Buccal Tablets
• Sublingual Tablets
• Implants

7. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 8.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 9.1. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• 9.2. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 10.1. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 11.1. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• 11.2. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 12.1. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 13.1. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 14.1. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• 14.2. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 15.1. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• 15.2. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 16.1. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 17.1. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 18.1. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 19.1. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 20.1. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 21.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• 21.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 22.1. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 23.1. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• 23.2. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 24.1. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• 24.2. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 25.1. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• 25.2. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 26.1. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• 26.2. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 27.1. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 28.1. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• 28.2. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 29.1. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• 29.2. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Landscape
• 30.2. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Lonza Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. WuXi Biologics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Samsung Biologics Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Other Major And Innovative Companies

• 31.1. Recipharm AB
• 31.2. Siegfried Holding AG
• 31.3. Evonik Industries AG
• 31.4. Almac Group
• 31.5. Aenova Group
• 31.6. Piramal Pharma Limited
• 31.7. Cambrex
• 31.8. Jubilant Pharmova Limited
• 31.9. CordenPharma
• 31.10. Altasciences
• 31.11. Hovione
• 31.12. Aurigene Pharmaceutical Services Ltd.
• 31.13. DPT Laboratories Ltd.
• 31.14. CARBOGEN AMCIS
• 31.15. Biopharma Group

32. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

34. Recent Developments In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

35. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer